SELECT FROM MENU

Therapy Areas
Drug Classes

       Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Advanced NSCLC

Advanced NSCLC

SCLC

SCLC

Biomarkers

Biomarkers

       Drug Classes

Targeted Therapies

Targeted Therapies

Immunotherapies

Immunotherapies

ADCs

ADCs

Alessandra Curioni-Fontecedro

Alessandra Curioni-Fontecedro

University of Fribourg, Fribourg

Prof. Alessandra Curioni-Fontecedro is Full Professor of Oncology at the University of Fribourg and Head of Medical Oncology at the Hôpital Fribourgeois (HFR) in Fribourg, Switzerland. She directs the Laboratory of Applied Cancer Research, where her work centers on thoracic malignancies — lung cancer and mesothelioma — with a focus on immunotherapy, mechanisms of resistance to immune checkpoint inhibitors, and the tumor microenvironment. She is President of the Lung Cancer Project Group of the Swiss Group for Clinical Cancer Research (SAKK) and coordinates the Lung Cancer Programme of the European School of Oncology (ESO). She is a frequent speaker at major international thoracic oncology congresses.

Connect

Alessandra Curioni-Fontecedro

Featured in